O-GlcNAcase promotes dendritic spine morphogenesis while downregulating their GluA2-containing AMPA receptors.

Linkun Han1, Sabrina Galizia1, Jingyu Pan1

  • 1Department of Clinical sciences, Umeå University, Umeå, Sweden; Department of Medical Translational Biology, Umeå University, Umeå, Sweden; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.

PubMed
Summary

O-GlcNAcase (OGA) regulates dendritic spine development and synapse size. This enzyme is crucial for synaptic plasticity and may be a therapeutic target for brain disorders like Alzheimer's disease and autism.